Recent advances in tumor vasculature targeting using liposomal drug delivery systems

By Abu Lila Amr S   Ishida Tatsuhiro   Kiwada Hiroshi  

Expert Opinion on Drug Delivery, Vol. 6, Iss. 12, 2009-12 ,pp. : 1297-1309

Informa Healthcare

Access to resources Recommend Favorite

Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy

By Chen Yunching   Huang Leaf  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 12, 2008-12 ,pp. : 1301-1311

Informa Healthcare

Access to resources Recommend Favorite

Quality of life in head and neck cancer patients after tumor therapy and subsequent rehabilitation: an exploratory study

By Nagy Judit   Braunitzer Gábor   Antal Márk   Berkovits Csaba   Novák Péter   Nagy Katalin  

Quality of Life Research, Vol. 23, Iss. 1, 2014-02 ,pp. : 135-143

Springer Publishing Company

Access to resources Recommend Favorite

Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development

By Plum S.M.   Holaday J.W.   Ruiz A.   Madsen J.W.   Fogler W.E.   Fortier A.H.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1294-1303

Elsevier

Access to resources Recommend Favorite

Cationic nanoparticles for cancer therapy

By Bilensoy Erem  

Expert Opinion on Drug Delivery, Vol. 7, Iss. 7, 2010-07 ,pp. : 795-809

Informa Healthcare

Access to resources Recommend Favorite